NexGenEsis Healthcare
Formerly known as National Gutter Franchise
Bottom line
- Total investment $168K – $363K including a $55K franchise fee.
- Average unit revenue of $2.0M/year (median $964K). Estimated payback in 0.5 years.
- Rated STRONG with a risk score of 47/100.
- Auditor disclosed a going-concern note — flagged doubt about the franchisor's ability to continue operations. Verify against the latest FDD.
Item 1 · who you're contracting with
The Franchisor
Yale framework · single-unit ROIC
Returns Analysis
Pulls Item 7 (investment) and Item 19 (revenue) from this brand's FDD into the Yale unlevered-ROIC formula. Override any input to stress-test it against your own assumptions.
The model · Yale framework
What would one NexGenEsis Healthcare unit return on the cash you put in?
Unlevered ROIC · per unit
97%
Above typical band (30–60%)
Levered LBO scenario · Yale Crease Capital framing
What would 25 NexGenEsis Healthcare units return on equity?
Equity IRR · 5-yr
30.9%
3.84× MOIC
Year-1 DSCR
2.61×
EBITDA ÷ debt service
Equity required
$7.7M
on $18.1M purchase
Total debt
$10.4M
SBA $5.0M + senior + seller note
Overview
About
NexGenEsis Healthcare franchisees likely operate healthcare service delivery, staffing, or telehealth operations. Daily operations typically involve patient/client management, clinical staff coordination, regulatory compliance, and revenue cycle management specific to healthcare verticals.
Item 7 · what it costs
The Vitals
Item 19
Financial Performance
Item 20 · unit dynamics
The Growth Chart
Year-over-year franchised unit counts and net change. Source: FDD Item 20.
Item 20 · 13 states with active franchisees
The Territory Map
Derived from franchisee contact records. Shows states with at least one current operator — not where the franchisor is registered to sell new units (that data is re-extracting in a future refresh).
States derived from franchisee phone area codes (Item 20). Approximate — ported numbers may show the original state, not the franchisee's current location.
Government records
SBA Loan Data
Aggregated from SBA 7(a) loan disclosures, public data unique to FranchiseVerdict.
No SBA loan data available for this brand.
FranchiseVerdict rating + FDD Items 3, 5, 6, 12, 17
Risk & Legal
Rapidly scaling early-stage healthcare franchise with unverified unit economics, opaque financial disclosure, and high minimum royalties creates elevated risk despite strong headline metrics.
Score breakdown · what drove the 47 / 100 rating
- 01MINORExplosive 200% YoY unit growth (14 units) suggests either aggressive recruitment or unsustainable expansion with unproven unit economics
- 02MINORHigh royalty floor ($500/month minimum) creates cash flow burden even for underperforming locations—problematic given only 14 units suggest immaturity
- 03MINORWide investment range ($168K–$363K) indicates inconsistent cost structure or territory-dependent pricing, reducing predictability
- 04MEDNo Item 19 (Franchisor Financial Performance) disclosed; cannot independently verify claimed $2M avg revenue and $536K net income
- 05MINORYoung franchise system (14 units) with minimal operating history; cannot validate sustainability of growth trajectory or franchisee profitability
Severity inferred from the FDD text · not a regulatory classification
FDD Items 5, 6, 12, 17 · continued from Risk & Legal
Contract & Territory Detail
Item 11
Training & Operations
Item 20
Franchisee Contacts
Phone numbers extracted directly from this brand's FDD Item 20. After purchase, you'll also receive a list of validation questions tailored to this brand.
Franchisee contacts
13 numbers
One-time purchase · CSV download · Validation questions included
FDD download
NexGenEsis Healthcare · FDD (2025) PDF